Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
38.20%
Grew
—
—
Shrank
—
1 Year
Score—
Net Growth38.20%
Net TrendGrew
Net Income Consistency—
Rev Growth—
Rev TrendShrank
Revenue Consistency—
5 Years
2.1
-415.38%
40%
—
-100.00%
20%
—
5 Years
Score2.1
Net Growth-415.38%
Net Trend40%
Net Income Consistency—
Rev Growth-100.00%
Rev Trend20%
Revenue Consistency—
Pliant Therapeutics Inc fundamental performance
Between 2020 and 2025, revenue declined from $ 41M to $ 0.00 and net income went from -$ 39M to -$ 149M. Revenue increased in 1 of those 5 years; net income in 2.
Pliant Therapeutics Inc currently holds a 5-year HDB Score of 2.1 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-13 | $ 1.08 | — |
1 Year2025-08-13 | $ 1.60 | -32.50% |
5 Years2021-08-13 | $ 19.82 | -94.55% |
All Time2020-06-03 | $ 21.30 | -94.93% |
| Period | Last Price2026-08-13 | 1 Year2025-08-13 | 5 Years2021-08-13 | All Time2020-06-03 |
|---|---|---|---|---|
| Price | $ 1.08 | $ 1.60 | $ 19.82 | $ 21.30 |
| Return | — | -32.50% | -94.55% | -94.93% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 0.00 | -$ 92M | $ 158M |
| 2025 | $ 0.00 | -$ 149M | $ 190M |
| 2024 | $ 0.00 | -$ 210M | $ 355M |
| 2023 | $ 1M | -$ 161M | $ 494M |
| 2022 | $ 9M | -$ 123M | $ 331M |
| 2021 | $ 7M | -$ 17M | $ 200M |
| IPO2020 | $ 41M | -$ 39M | $ 276M |
Explore beyond PLRX
You're looking at Pliant Therapeutics Inc. Members apply the same fundamental framework across all 3,859 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,859 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
